Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bloch

Showing results (111-120 of 672) with videos related to

Pageof 68
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|June 9, 2011
Catheter-based renal sympathetic nerve ablation controls blood pressure in more difficult-to-control patients taking multi-agent pharmacologic therapyMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|December 7, 2011
UK guidelines call for routine 24-hour ambulatory blood pressure monitoring in all patients to make the diagnosis of hypertension--not ready for prime time in the United StatesMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 1, 2012
The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing boardMichael J Bloch, Jan N Basile
The Journal of Cell Biology|March 1, 1987
The relationship of the postsynaptic 43K protein to acetylcholine receptors in receptor clusters isolated from cultured rat myotubesR J Bloch, S C Froehner
Developmental Biology|January 30, 1981
Reversible loss of acetylcholine receptor clusters at the developing rat neuromuscular junctionR J Bloch, J H Steinbach
Journal of Clinical Hypertension (Greenwich, Conn.)|January 29, 2011
Patient self-management improves blood pressure controlMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|July 2, 2010
Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionableMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Percutaneous revascularization of the renal arteries offers no evidence of clinical benefit in patients with atherosclerotic renal artery stenosis--the ASTRAL trialMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|August 22, 2009
Prior incarceration is associated with an increased risk for developing hypertensionMichael J Bloch, Jan N Basile
Nephrologie & Therapeutique|July 7, 2009
[Monitoring the quality of life of end-stage renal disease patients. Quality of life report - REIN - Dialysis 2005]S Boini, J Bloch, S Briançon
Pageof 68

Showing results (111-120 of 672) with videos related to

Sort By:
Pageof 68
Journal of Clinical Hypertension (Greenwich, Conn.)|June 9, 2011
Catheter-based renal sympathetic nerve ablation controls blood pressure in more difficult-to-control patients taking multi-agent pharmacologic therapyMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|December 7, 2011
UK guidelines call for routine 24-hour ambulatory blood pressure monitoring in all patients to make the diagnosis of hypertension--not ready for prime time in the United StatesMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 1, 2012
The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing boardMichael J Bloch, Jan N Basile
The Journal of Cell Biology|March 1, 1987
The relationship of the postsynaptic 43K protein to acetylcholine receptors in receptor clusters isolated from cultured rat myotubesR J Bloch, S C Froehner
Developmental Biology|January 30, 1981
Reversible loss of acetylcholine receptor clusters at the developing rat neuromuscular junctionR J Bloch, J H Steinbach
Journal of Clinical Hypertension (Greenwich, Conn.)|January 29, 2011
Patient self-management improves blood pressure controlMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|July 2, 2010
Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionableMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|May 4, 2010
Percutaneous revascularization of the renal arteries offers no evidence of clinical benefit in patients with atherosclerotic renal artery stenosis--the ASTRAL trialMichael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|August 22, 2009
Prior incarceration is associated with an increased risk for developing hypertensionMichael J Bloch, Jan N Basile
Nephrologie & Therapeutique|July 7, 2009
[Monitoring the quality of life of end-stage renal disease patients. Quality of life report - REIN - Dialysis 2005]S Boini, J Bloch, S Briançon
Pageof 68